Jorveza 1 mg orodispersible tablets

Double-blind, double-dummy, randomized, parallel-group, non-inferiority phase III trial on the efficacy and tolerability of 2 mg once daily vs. 1 mg twice daily budesonide orodispersible tablets for induction of histological remission in adults with eosinophilic esophagitis

Budesonide as a treatment for low-grade duodenal inflammation in functional dyspepsia.